Steven C Cramer,Livia Parodi,Zahra Moslemi,Robynne G Braun,Chad M Aldridge,Babak Shahbaba,Jonathan Rosand,E Alison Holman,STRONG Study Investigators,Shreyansh Shah,Christoph J Griessenauer,Nirav Patel,Christopher Anderson,Jonathan Henry,Christina Kourkoulis,David J Lin,Natalie Zaba,Joey Gee,Johnson Moon,Julie Schwertfeger,Arun Jayaraman,Robert Lee,Maarten G Lansberg,Stephanie Kemp,Emily Huang,Elijah Bingham,Leonel Lugo,Da Eun Katie Eun,Jeremy Payne,Carolynn Patten,Kwan Ng,Madelyn Cao,Ashley Jubb,Breann McGee,Ryan Shahbaba,Kunal Agrawal,Brett Kissela,Stacey DeJong,John Cole,Brian Silver,Christina Manxhari,Brett Cucchiara,Ania Busza,Jennifer Paige Hepple,Sook-Lei Liew,Susan Alderman,Jennifer Beauchamp,Nitha Joseph Mathew,Heather Hayes,Jennifer J Majersik,Bradford B Worrall,David Tirschwell,Cheryl Bushnell,Nada El Husseini,Jin-Moo Lee,Guido J Falcone

Abstract:Background: Genetic association studies can reveal biology and treatment targets but have received limited attention for stroke recovery. STRONG (Stroke, Stress, Rehabilitation, and Genetics) was a prospective, longitudinal (1-year), genetic study in adults with stroke at 28 US stroke centers. The primary aim was to examine the association that candidate genetic variants have with (1) motor/functional outcomes and (2) stress-related outcomes. Methods: For motor/functional end points, 3 candidate gene variants (ApoE ε4, BDNF [brain-derived neurotrophic factor], and a dopamine polygenic score) were analyzed for associations with change in grip strength (3 months-baseline), function (3-month Stroke Impact Scale-Activities of Daily Living), mood (3-month Patient Health Questionnaire-8), and cognition (12-month telephone-Montreal Cognitive Assessment). For stress-related outcomes, 7 variants (serotonin transporter gene-linked promoter region, ACE [angiotensin-converting enzyme], oxytocin receptor, FKBP5 [FKBP prolyl isomerase 5], FAAH [fatty acid amide hydrolase], BDNF, and COMT [catechol-O-methyltransferase]) were assessed for associations with posttraumatic stress disorder ([PTSD]; PTSD Primary Care Scale) and depression (Patient Health Questionnaire-8) at 6 and 12 months; stress-related genes were examined as a function of poststroke stress level. Statistical models (linear, negative binomial, or Poisson regression) were based on response variable distribution; all included stroke severity, age, sex, and ancestry as covariates. Stroke subtype was explored secondarily. Data were Holm-Bonferroni corrected. A secondary replication analysis tested whether the rs1842681 polymorphism (identified in the GISCOME study [Genetics of Ischaemic Stroke Functional Outcome]) was related to 3-month modified Rankin Scale score in STRONG. Results: The 763 enrollees were 63.1±14.9 (mean±SD) years of age, with a median initial National Institutes of Health Stroke Scale score of 4 (interquartile range, 2-9); outcome data were available in n=515 at 3 months, n=500 at 6 months, and n=489 at 12 months. At 1 year poststroke, the rs6265 (BDNF) variant was associated with poorer cognition (0.9-point lower telephone-Montreal Cognitive Assessment score, P=1×10-5). For stress-related outcomes, rs4291 (ACE) and rs324420 (FAAH) were risk factors linking increased poststroke stress with higher 1-year depression and PTSD symptoms (P<0.05), while rs4680 (COMT) linked poststroke stress with lower 1-year depression and PTSD. Findings were unchanged when considering stroke subtype. STRONG replicated GISCOME: rs1842681 was associated with lower 3-month modified Rankin Scale score (P=3.2×10-5). Conclusions: This study identified genetic associations with cognitive function, depression, and PTSD 1 year poststroke. Genetic susceptibility to PTSD and depressive symptoms varied according to the amount of poststroke stress, underscoring the critical role of lived experiences in recovery. Together, the results suggest that genetic association studies provide insights into the biology of stroke recovery in humans.

Abstract 122: Associations of BDNF, PATJ and LOC105372028 Polymorphisms With Functional Outcomes in Probable LVO

Influence of Occlusion Site and Baseline Ischemic Core on Outcome in Patients with Ischemic Stroke.

Missense Variants in Hypoxia-Induced VEGFA/VEGFR2 Signaling Predict the Outcome of Large Artery Atherosclerotic Stroke

Rare Variant Association Analysis Uncovers Involvement of VNN2 in Stroke Outcome

Does Large Vessel Occlusion Affect Clinical Outcome in Stroke with Mild Neurologic Deficits after Intravenous Thrombolysis?

Abstract 119: Stroke Recovery and Genetic Variation: Main Results of the STRONG Study

Predictors of favorable functional outcomes for elderly patients undergoing endovascular thrombectomy for acute ischemic stroke

Abstract TP149: Pretreatment Parameters Predicting Excellent Recanalization of Large Vessel Occlusion in Patients With Acute Ischemic Stroke

Abstract WP2: Natural History of Large Vessel Occlusion Patients Presenting With Minor Stroke Symptoms

TNFRSF11B Polymorphisms Predict Poor Outcome after Large Artery Atherosclerosis Stroke.

Distinct intra-arterial clot localization affects tissue-level collaterals and venous outflow profiles

Genetic Variation and Stroke Recovery: The STRONG Study

Large-Vessel Occlusion is Associated with Poor Outcome in Stroke Patients Aged 80 Years or Older Who Underwent Intravenous Thrombolysis.

Genetics of ischemic stroke functional outcome

Abstract TP82: Effect of Stroke Etiology and Treatment Intervention for Young Adults With Large Vessel Occlusion- Acute Ischemic Stroke: Results From the Cleveland Clinic Young Adult Retrospective Cohort Study

The Benefit of Favorable Venous Outflow Profile is Mediated Through Reduced Microvascular Dysfunction in Acute Ischemic Stroke.

Abstract 2607: A GWAS From The Vitamin Intervention For Stroke Prevention (VISP) Clinical Trial Identifies Variants That Contribute To Recurrent Stroke And Combined Vascular Endpoints

Improving Stroke Outcome Prediction Using Molecular and Machine Learning Approaches in Large Vessel Occlusion

Systematic Druggable Genome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Functional Outcome after Ischemic Stroke

Abstract 86: Outcomes of Endovascular Therapy for Late Large Vessel Occlusion in Patients With Pre-Stroke Disability

Pre-treatment radiological factors associated with poor functional outcome in an Asian cohort of large vessel occlusion acute ischemic stroke patients undergoing mechanical thrombectomy